Blog

Careers

Advertise

Contact

logo
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2022
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • Resources
  • About
    • Mission
    • What Is A GPO ?
    • Policy Positions
    • HSCA Committees
    • Member Organizations
    • FAQ
    • Leadership
    • HSCA Staff
    • Contact
  • Events
    • National Pharmacy Forum 2022
    • Past Events
  • CHeS
    • CHeS Total Visibility Project
    • CHeS Membership
    • CHeS Resources
  • Issues
  • Resources
    • Studies
    • Hospital Testimonials
    • Supplier Endorsements
    • Small Supplier Portal
    • Congressional Resources
    • COVID-19 Recommendations
    • COVID-19 Response Efforts
  • News
  • Resources

HSCA Statement on FDA Drug Shortages Task Force Report

October 29, 2019 by Brigid Hasson 2019 Press Releases 0 comments

Washington, DC (October 29, 2019) – Healthcare Supply Chain Association (HSCA) President and CEO Khatereh Calleja today released the following statement regarding the recent report by the Food and Drug Administration (FDA) Drug Shortages Task Force on drug shortages:

“Ongoing critical prescription drug shortages jeopardize patient access to essential medications. As FDA has noted, the causes of drug shortages are complex and multifactorial, requiring an all-hands-on-deck, multi-stakeholder solution. HSCA and its member group purchasing organizations (GPOs) are on the front lines of helping providers prevent and mitigate drug shortages, working collaboratively with hospitals, physicians, manufacturers, distributors, and government agencies to ensure that providers and patients have access to the life-saving drugs they need.

Click here to read the full release.

Prev
Next

Related Posts

HSCA Announces 2019 Board of Directors and Names GNYHA Ventures President Lee Perlman Board Chair
January 24, 2019

Washington, DC (January, 2019) – The Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Statement on House Committee on Homeland Security Hearing on the Coronavirus
March 11, 2020

Washington, DC (March 11, 2020) – Healthcare Supply Chain Association (HSCA)...

Learn more
HSCA Releases Third Annual Report on Value GPOs Deliver to the Healthcare Supply Chain
March 24, 2020

Washington, DC (March 24, 2020) – The Healthcare Supply Chain Association (HSCA),...

Learn more
New Analysis of U.S. Health Data Finds Healthcare Group Purchasing Organizations Save Healthcare System, Medicare and Medicaid, and Taxpayers Up to $34.1 Billion Annually
May 15, 2019

Analysis of CMS expenditure data finds that GPOs will reduce healthcare spending...

Learn more

Our Office

Healthcare Supply Chain Association
1341 G Street NW Suite 600
Washington, DC 20005

Phone: 202.629.5833
Fax: 202.466.9666
Email: info@supplychainassociation.org

LATEST NEWS

  • ANALYSIS: GPOs Helped Increase Domestic Manufacturing Capacity, Protected Hospitals and Patients from Thousands of Fraudulent Sellers, and Helped Identify and Bring New Suppliers to Market to Avert Supply and Drug Shortages During COVID-19
    April 20, 2022
  • HSCA Comments to the Senate Committee on Health, Education, Labor, and Pensions on the PREVENT Pandemics Act
    April 1, 2022